The Necrotising Enterocolitis Market Is Driven By Rising Preterm Birth Rates

By Author: colin
Total Articles: 166
Comment this article

The necrotising enterocolitis market consists of drugs that are used for the treatment of necrotising enterocolitis, which is a disease that affects premature infants. Necrotising enterocolitis is a devastating gastrointestinal emergency that mainly affects premature infants. It is the necrosis of the intestinal tissue and perforation of the bowel. The drugs used in the treatment of necrotising enterocolitis aim to reduce inflammation, treat infections, provide nutritional support, and in severe cases, perform surgery. Some of the commonly used drugs are antibiotics, blood plasma expanders, intravenous immunoglobulins, and antifungal drugs.
The Necrotising Enterocolitis Market is estimated to be valued at US$ 7.10 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024-2031.
Prematurity is the greatest risk factor for necrotising enterocolitis, as the intestinal tract of preterm infants is underdeveloped and has not completed maturation. With rising preterm birth rates globally due to the increased risk of preterm birth associated with infertility treatments, multiple pregnancies, etc. ...
... the risk of necrotising enterocolitis is also increasing.
Key Takeaways
Key players operating in the necrotising enterocolitis market are AbbVie, AstraZeneca, Baxter International, Bristol-Myers Squibb, and Fresenius Kabi.
The rising preterm birth rates globally have led to increased demand for drugs to treat necrotising enterocolitis. According to the World Health Organization, preterm birth complications are the leading cause of death among children under 5 years of age.
Major pharmaceutical companies have been expanding their geographical presence and conducting clinical trials for newer drugs to target the growing necrotising enterocolitis market globally especially in developing countries.
Market Drivers
Rising preterm birth rates is the major driver of the necrotising enterocolitis market. According to the Centers for Disease Control and Prevention (CDC), nearly 1 of every 10 infants in the United States is born preterm. Prematurity is associated with nearly 80% of necrotising enterocolitis cases. Therefore, with increasing preterm births, the cases of necrotising enterocolitis are also expected to rise significantly thereby driving the demand for drugs to treat this condition.
Current Geopolitical Situation Impacting The Necrotising Enterocolitis Market Growth
The ongoing geopolitical conflicts and economic uncertainties across several regions are adversely impacting the growth of the necrotising enterocolitis market. The supply chain disruptions caused due to regional trade restrictions and sanctions have limited the international availability of key drugs and medical devices required for NEC treatment. Moreover, the shifting government priorities and fund allocations towards addressing public health challenges of ongoing wars and health crises have reduced support for neonatal care research & development. This poses significant challenges for market players to expand access to advanced NEC treatment options in affected nations. However, robust economic growth and increasing healthcare investments in developing Asian and Latin American countries provide new opportunities for market expansion.
To sustain long-term growth, companies must look for strategic partnerships in politically stable emerging markets and focus on developing affordable drugs & technologies. Establishing local manufacturing facilities and supply chain resilience must be priority to mitigate geopolitical risks. Market players also need to actively support humanitarian organizations treating NEC in conflict regions through sustained donations & aid. At the policy level, international collaboration on addressing NEC can ensure continued progress is made, irrespective of ongoing global uncertainties.
Geographical Regions Where Market Is Concentrated
The necrotising enterocolitis market presently witnesses highest concentration in terms of value in North America due to strong healthcare infrastructure, high awareness about NEC, and presence of leading market players. The United States contributes over 35% of global market revenue aided by well-established private and public insurance coverage for neonatal healthcare. Western Europe represents another major revenue pocket with Germany and United Kingdom among the top markets. Rising affluence and healthcare reforms have boosted the number of preterm births and NEC survival rates in these regions.
Fastest Growing Region For The Necrotising Enterocolitis Market
Asia Pacific region is expected to showcase the fastest value growth during the forecast period supported by expanding neonatal intensive care units, availability of advanced treatment options, and improving access to healthcare in populous developing nations. In particular, China and India are emerging as high potential markets accounting for over 25% of global preterm births annually. This coupled with increasing privatization of healthcare and initiatives to reduce neonatal mortality make Asia Pacific an attractive investment destination for key players.

Get more insights on this topic: https://heyjinni.com/read-blog/135850

About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

What Are The Key Data Covered In This Necrotising Enterocolitis Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Necrotising Enterocolitis Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Necrotising Enterocolitis Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Necrotising Enterocolitis Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Necrotising Enterocolitis Market vendors
FAQ’s
Q.1 What are the main factors influencing the Necrotising Enterocolitis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Necrotising Enterocolitis Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Necrotising Enterocolitis Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it